CASSS - An International Separation Science Society

Conference History 






ASIA  

December 3-4, 2012 Tokyo, Japan

EUROPE  

23 - 25 April 2012 Berlin, Germany

21 - 23 March 2011 Barcelona, Spain
Improving Biopharmaceutical Product Quality: Moving Implementation Forward

25 - 27 May 2010 Vienna, Austria
Challenges Facing Biopharmaceutical Development in the Next Decade

27 - 29 April 2009 Lisbon, Portugal
CMC Perspectives on Biological Investigational Medicinal Products in Clinical Trials

8 - 9 April 2008  Paris, France
Staging of CMC Requirements Throughout the Product Development Cycle

8 - 9 March 2007  Brussels, Belgium
Life Cycle Approach for Specifications
Click here for summary paper. (NOTE: This paper was not published.)

UNITED STATES

January 27, 2013 Washington, DC

January 22, 2012 San Francisco, California
Biosimilar Products: Scientific Principles, Challenges, Opportunities

Rapid Pharmaceutical Product Development: Getting Off the Critical Path and onto the Right Path

August 1-2, 2011 Bethesda, Maryland
Challenges and Considerations for Multiproduct Facility Design and Control for Biologics

January 9, 2011 Washington, DC
A Practical Approach to the Analysis and Immunogenic Potential of Aggregates and Particles

July 19-20, 2010 Bethesda, Maryland
QbD for Biologics: Learning's from the Product Development and Realization Case Study (A-Mab) and the FDA OBP Pilot Program

January 24, 2010 Washington, DC
Analytical Characterization and Regulatory Considerations for Antibody-Drug Conjugates: Uniting Small Molecule and Biologic Drug Perspectives

The Role of Higher Order Structure in Defining the Quality of Biopharmaceutical Products
The summary paper has been published in BioProcess International (Volume 9, Number 4, April 2011).
Click here for summary paper.

July 27-28, 2009 Bethesda, Maryland
Practical Applications of Quality Risk Management
The summary paper has been published in BioProcess International (Volume 8, Number 3, March 2010).
Click here for summary paper.

January 11, 2009 San Francisco, California
Raw Material Control Strategies for Bioprocesses
The summary paper has been published in BioProcess International (Volume 7, Number 8, September 2009).
Click here for summary paper.

July 24 - 25, 2008 Bethesda, Maryland
Quality by Design - The Next Phase: Approach for Filing the QbD Data and Potential Regulatory Implications
The summary paper has been published in BioProcess International (Volume 7, Number 1, January 2009).
Click here for summary paper.

January 27 - 28, 2008 Washington, DC
Extractables and Leachables: Challenges and Strategies in Biopharmaceutical Development
The summary paper has been published in BioProcess International (Volume 9, Number 2, Febuary 2011).
Click here for summary paper.

Current Practices for Assessing the Comparability and Stability of Gene Therapy Products

July 16 - 17, 2007 Bethesda, Maryland
Quality by Design (QbD) for Biopharmaceuticals
The summary paper has been published in BioProcess International (Volume 7, Number 1, January 2009).
Click here for summary paper.

January 28, 2007 Washington, DC
Binding Assays and Bioassays: What Are Their Roles in Lot Release and Stability Testing?
The summary paper has been published in BioProcess International (Volume 8, Number 6, June 2010).
Click here for summary paper.

Glycosylation of Therapeutic Proteins: Current Understanding of Structure-Function Relationship

July 20 - 21, 2006 Bethesda, Maryland
Changing the Paradigm of Process Validation

January 23, 2006 San Francisco, California
Standard Reference Materials for Biopharmaceutical Products: Strategies to Support Product and Method Specifications
The summary review has been published in The Gold Sheet (Volume 40, Number 6, June 2006).
Click here for summary review.

July 25 - 26, 2005 Bethesda, Maryland
Design and Successful Implementation of a Stability Program for Biotechnology-Derived Products
The summary review has been published in The Gold Sheet (Volume 39, Number 10, October 2005).
Click here for summary review.

January 9, 2005 Washington, DC
Demonstrating Comparability for Well-Characterized Biotechnology Products: Early Phase, Late Phase and Post Approval
The summary paper has been published in BioProcess International (Volume 6, Number 2, February 2008).
Click here for summary paper.

Lot Release and Characterization Testing of Live-Virus-Based Vaccine and Gene Therapy Products
The part one summary paper has been published in BioProcess International (Volume 4, Number 4, April 2006).
Click here for part one summary paper.
The part two summary paper has been published in BioProcess International (Volume 4, Number 5, May 2006).
Click here for part two summary paper.

July 19 - 20, 2004 Bethesda, Maryland
Defining Your Product Profile and Maintaining Control Over It: Process-Related Impurities
The summary paper has been published in BioProcess International (Volume 3, Number 6, June 2005).
Click here for summary paper.

Defining Your Product Profile and Maintaining Control Over It: The Challenges of Monitoring Host Cell Protein Impurities
The summary paper has been published in BioProcess International (Volume 3, Number 6, September 2005).
Click here for summary paper.

Defining Your Product Profile and Maintaining Control Over It: Product-Related Impurities
The summary paper has been published in BioProcess International (Volume 3, Number 9, October 2005).
Click here for summary paper.

Defining Your Product Profile and Maintaining Control Over It: Product-Related Impurities-Tackling Aggregates
The summary paper has been published in BioProcess International (Volume 3, Number 10, November 2005).
Click here for summary paper.

January 5, 2004 Washington, DC
Life Cycle Approach to Setting Specifications for Biotechnology-Derived Products
The summary review has been published in The Gold Sheet (Volume 38, Number 9, September 2004).
Click here for summary review.

September 19, 2003 Philadelphia, Pennsylvania
Mycoplasma In-Process and Lot Release Test: To PCR Or Not To PCR
The summary paper has been published in BioProcess International (Volume 3, Number 11, December 2005).
Click here for summary paper.

July 24, 2003 Gaithersburg, Maryland
What Is Test Method Qualification?
The summary paper has been published in BioProcess International (Volume 2, Number 8, September 2004).
Click here for summary paper.

January 6, 2003 San Francisco, California
Analysis and Structure Characterization of Monoclonal Antibodies
The summary paper has been published in BioProcess International (Volume 2, Number 2, February 2004).
Click here for summary paper.

September 19, 2002 Boston, Massachusetts
Strategies to Establish Release Specifications for Peptide Maps
The summary paper has been published in BioPharm International (Volume 16, Number 4, April 2003).
Click here for summary paper.


 


  

 

 

CASSS - An International Separation Science Society   |   5900 Hollis Street, Suite R3 Emeryville, CA 94608   |   Ph: 510.428.0740   |   Fax: 510.428.0741

Privacy Policy © Copyright 2013, All Rights Reserved - CASSS